Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of GAB1 mRNA | increases expression | 19933214
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of GAB1 mRNA | decreases expression | 20406850
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of GAB1 mRNA | affects expression | 17484886
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of GAB1 mRNA | increases expression | 18042831
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of GAB1 mRNA | increases expression | 16002434
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of GAB1 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of GAB1 mRNA | decreases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GAB1 mRNA | affects cotreatment|decreases expression | 17942748
|
D006820 |
Hyaluronic Acid |
Hyaluronic Acid results in increased phosphorylation of GAB1 protein | increases phosphorylation | 16864594
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of GAB1 mRNA | increases expression | 19339665
|
D008070 |
Lipopolysaccharides |
methyldithiocarbamate promotes the reaction [Lipopolysaccharides results in increased expression of GAB1 mRNA] | increases expression|increases reaction | 19339665
|
C008435 |
methyldithiocarbamate |
methyldithiocarbamate promotes the reaction [Lipopolysaccharides results in increased expression of GAB1 mRNA] | increases expression|increases reaction | 19339665
|
C041786 |
palm oil |
palm oil results in increased expression of GAB1 mRNA | increases expression | 18042831
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [AGT protein results in increased phosphorylation of and results in increased localization of GAB1 protein] | decreases reaction|increases localization|increases phosphorylation | 15849355
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased localization of GAB1 protein] | decreases reaction|increases localization|increases phosphorylation | 15849355
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of GAB1 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GAB1 mRNA | affects cotreatment|decreases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of GAB1 mRNA | increases expression | 19933214
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.68 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.96 | 15322242 14514962 11752688 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.08 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.93 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
4.12 | 11850527 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.83 | 14692618 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.36 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.49 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.58 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.02 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
10.26 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
10.26 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.52 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
7.52 | 17115116 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.32 | 16873680 17967414 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.12 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.81 | 15746008 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.40 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.36 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.36 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.36 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.36 | 17242785 15668708 16818667 19142967 19289846 19189210 19244106 19189212 19288272 19066611 18425577 20544844 21138602 19221464 16273361 19115204 19410462 18997820 20390343 18855134 20859285 20135344 17261762 18351453 20005174 18815881 17049068 11161223 18984771 15565566 19059307 16202921 19487384 18629630 19103187 20065188 17440819 19084267 19200415 19155303 16873071 19011961 21152245 18821012 17893378 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.36 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.88 | 16192424 16227642 3786805 15700767 16050911 15673190 18705752 15721981 16011737 16124888 16097048 10355542 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.86 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.61 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.70 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
6.70 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
6.70 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
6.70 | 16924424 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.71 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
5.01 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
5.01 | 16227395 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.69 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.53 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.82 | 6135515 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.93 | 17110522 16919318 15861022 16105132 17333356 17681005 11677210 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 15668235 12621046 15340226 16354765 8697196 |
MESH:D003092 |
Colitis |
|
resveratrol |
4.23 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.47 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.22 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.80 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 20055451 10048152 15322242 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.12 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.47 | 19031437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.84 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
9.29 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
9.29 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.31 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
6.31 | 16177239 4309450 11566570 15968718 19336974 7179309 6884620 7440962 6623471 15027814 10092053 19085960 3786805 2869522 15998439 9327722 3732212 10915739 7120509 17522070 21278145 16227642 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.31 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.82 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.51 | 18367378 |
MESH:D004487 |
Edema |
|
resveratrol |
7.13 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.13 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
22.77 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
22.77 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
22.77 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
22.77 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.10 | 16202921 20544844 17893378 19155303 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.51 | 17637181 15821434 15328337 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.95 | 17923197 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
19.47 | 19224547 12631006 17595544 12795759 16239168 15959796 61145 16045604 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
19.47 | 18296743 17967931 19551842 19004024 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
19.47 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
19.47 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.28 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
4.09 | 9205823 11852909 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.64 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.30 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
15.39 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
15.39 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
15.39 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.37 | 10048152 11294989 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.46 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.69 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.00 | 16120746 15340226 12621046 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.30 | 16876885 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 16959395 15340226 16354765 8697196 18606429 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.65 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
9.49 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
9.49 | 17188708 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
9.58 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
9.58 | 16873680 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.93 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.19 | 15338365 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.38 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.91 | 16945680 16569931 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.75 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.55 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.54 | 17937319 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
16.32 | 20412841 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
16.32 | 17237260 17255318 12878042 17963957 9205823 |
MESH:D007249 |
Inflammation |
|
resveratrol |
16.32 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
16.32 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
16.32 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.68 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.15 | 11836018 18457598 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.72 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.61 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
7.61 | 18625569 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.63 | 16087638 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.81 | 15821434 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.21 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.77 | 11903743 17157831 11408273 17174718 16943688 16221502 16239168 17334410 21278145 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
6.77 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
5.04 | 18412020 18279442 16638106 17721639 17698563 17761835 18054572 13678700 12649538 17805973 18472094 16248980 17922224 15673190 17557913 12632514 17714472 10355542 15931870 18205269 16015684 15338365 12445418 18210741 18251166 15730626 18376398 17708605 18395914 18166357 14512876 17976157 15370692 14724832 12666154 15959796 17823541 15893842 14716496 18339082 12546737 15996030 15818738 17766677 15925388 12958196 14620537 15123356 18006644 15876570 12898905 17900296 12389079 16027843 15052691 17640975 12632512 12586293 12741479 15057751 18418968 16192424 15362042 18277467 12609069 18705752 16116963 16136751 17481882 16011737 17525996 18481824 18156304 16033810 17631135 12445421 17944888 16097048 14748882 18187930 17565644 15650968 20821823 11481614 18472332 18420326 12667390 14716833 18429990 18317297 18395095 17869086 18263696 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
5.04 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
5.04 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
5.04 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.10 | 17285989 15720792 16964402 16246199 15830285 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.27 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.77 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
14.56 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
14.56 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
14.56 | 20405173 19812893 19321006 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
14.56 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.56 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
10.07 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
10.07 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.07 | 12151625 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
4.11 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.27 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.27 | 19555203 11884234 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.39 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.94 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
10.40 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
10.40 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
6.34 | 8985016 11606380 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.34 | 16827153 11731420 19196722 14580682 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.68 | 19453300 |
MESH:D008545 |
Melanoma |
|
resveratrol |
3.48 | 17992120 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.48 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.30 | 15990972 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.46 | 17112576 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.52 | 14749477 17164350 16267019 16490592 17935668 17049120 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.99 | 17962980 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
3.06 | 17125593 17188708 16456233 16525036 17015251 16317513 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
9.23 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.23 | 12213967 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.88 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.98 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.57 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.54 | 19410462 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
4.10 | 8985016 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.13 | 19200415 19189210 19196722 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.31 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.87 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.49 | 17929310 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.30 | 17217161 21332399 20132043 19632207 16723640 11836018 20518802 18457598 18674790 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.51 | 16049721 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.34 | 17513867 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.77 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.67 | 11605937 12224865 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
9.99 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.99 | 11399792 11896295 11118676 11222880 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.90 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.18 | 12479363 16289102 16644109 18247401 15754350 |
MESH:D011471 |
Prostatic Neoplasms |
|
Hyaluronic Acid |
2.18 | 16864594 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.18 | 17636462 16731767 17804756 15767336 17675339 17718901 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.18 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.43 | 15861022 16919318 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.72 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.31 | 16314181 15827377 17520802 17058453 16317513 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.78 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.59 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
5.84 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.84 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
12.01 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
12.01 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.15 | 19457130 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.56 | 16321402 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.24 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.71 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.22 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.29 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.13 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.13 | 17572228 16712894 8653321 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.43 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
4.18 | 17473185 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
9.82 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
9.82 | 17044934 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.62 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.41 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.81 | 16723640 |